"De locatie Erasmus MC-Daniel den Hoed bestaat niet meer. De patiëntenzorg is verhuisd naar Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam."

During the past decade, Daniel Den Hoed Cancer Center at Erasmus Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Daniel Den Hoed Cancer Center at Erasmus Medical Center" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 32 trials, followed by "Commissie Voor Klinisch Toegepast Onderzoek" with 5 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Medical Research Council" with 1 trials sponsored and "The Lymphoma Academic Research Organisation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Daniel Den Hoed Cancer Center at Erasmus Medical Center" #1 collaborator was "NCIC Clinical Trials Group" with 5 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Lymphoma Study Association" with 2 trials as a collaborator and "Medical Research Council" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Daniel Den Hoed Cancer Center at Erasmus Medical Center" are "Lymphoma" (6 trials), "Brain and Central Nervous System Tumors" (5 trials), "Sarcoma" (4 trials), "Bladder Cancer" (3 trials) and "Ovarian Cancer" (3 trials). Many other conditions were trialed in "Daniel Den Hoed Cancer Center at Erasmus Medical Center" in a lesser frequency.

Most popular intervention types in "Daniel Den Hoed Cancer Center at Erasmus Medical Center" are "Drug" (35 trials), "Procedure" (17 trials), "Biological" (14 trials), "Radiation" (13 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (12 trials), "adjuvant therapy" (8 trials), "conventional surgery" (7 trials), "filgrastim" (7 trials) and "cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Daniel Den Hoed Cancer Center at Erasmus Medical Center" are 34 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Daniel Den Hoed Cancer Center at Erasmus Medical Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Daniel Den Hoed Cancer Center at Erasmus Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Daniel Den Hoed Cancer Center at Erasmus Medical Center, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".